Spruce Biosciences (SPRB) Analyst & Key Data

Analyst Consensus

Buy11 analysts

Buy

Updated Sep 12, 2026

Total Analysts11

Buy

7

Hold

4

Ratings

Updated Sep 12, 2026

Overall Rating

C+

DCF Score4.0 / 5

Debt / Equity Score3.0 / 5

Price / Book Score3.0 / 5

Price / Earnings Score1.0 / 5

ROA Score1.0 / 5

ROE Score1.0 / 5

Valuation

Current Stock Price

$53.70

DCF Value+15.11%

$61.81

Potential upside vs current price

Current Stock Price

$53.70

DCF Value+15.11%

$61.81

Potential upside vs current price

Analyst Consensus

Buy11 analysts

Buy

Updated Sep 12, 2026

Total Analysts11

Buy

7

Hold

4

Ratings

Updated Sep 12, 2026

Overall Rating

C+

DCF Score4.0 / 5

Debt / Equity Score3.0 / 5

Price / Book Score3.0 / 5

Price / Earnings Score1.0 / 5

ROA Score1.0 / 5

ROE Score1.0 / 5

Valuation

Current Stock Price

$53.70

DCF Value+15.11%

$61.81

Potential upside vs current price

Current Stock Price

$53.70

DCF Value+15.11%

$61.81

Potential upside vs current price

Spruce Biosciences, Inc.